Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.

导出 OA

翻译打印收藏纠错

第一作者： Shinya,Urakawa

第一单位： Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

作者： Shinya,Urakawa ^[1] ; Makoto,Yamasaki ^[2] ; Kumiko,Goto ^[2] ; Miya,Haruna ^[1] ; Michinari,Hirata ^[3] ; Akiko,Morimoto-Okazawa ^[1] ; Atsunari,Kawashima ^[3] ; Kota,Iwahori ^[1] ; Tomoki,Makino ^[3] ; Yukinori,Kurokawa ^[1] ; Tomomi,Yamada ^[1] ; Masaki,Mori ^[1] ; Yuichiro,Doki ^[2] ; Hisashi,Wada ^[2]

作者单位： Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. ^[1] Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. ^[2] Drug Discovery and Disease Research Laboratory, Shionogi and Co., Ltd., Toyonaka, Osaka, Japan. ^[3] Department of Medical Innovation, Osaka University Hospital, Osaka, Japan. ^[4] Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ^[5] Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. hwada@gesurg.med.osaka-u.ac.jp. ^[6]

关键词 Biomarker Immunosuppression Post-operative monocyte count Prognosis